Your session is about to expire
← Back to Search
Medical Food - Anhydrous Enol-Oxaloacetate for Chronic Fatigue Syndrome
Study Summary
This trial will test if a potential new treatment, anhydrous enol-oxaloacetate (AEO), can help improve fatigue in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
- Chronic Fatigue Syndrome
- Fatigue
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals eligible to participate in this experiment presently?
"Per the documentation on clinicaltrials.gov, recruitment for this study has concluded as of February 28th 2022. This research was first listed on March 15th 2022 and is one out of 225 other trials currently looking to enrol participants."
Can geriatric individuals volunteer for this research investigation?
"This clinical trial seeks participants between the ages of 18-70. There are 13 distinct trials for minors, and another 179 available to those over 65 years old who meet other criteria."
What qualifications must a patient possess to partake in this trial?
"This clinical trial is recruiting 80 fatigued individuals aged 18-65. Participants must meet the following conditions to be eligible: provide written consent, have a basic command of English, satisfy IOM Diagnostic Criteria for ME/CFS (2015), report 2-6 hours daily upright activity in preceding 3 months, male or female gender, no active SARS-CoV-2 infection at enrollment visit 1 and adequate contraception such as oral contraceptives with one full cycle prior to administration of study drug; intrauterine devices (IUDs); vasectomized partner; double barrier method with spermicidal jelly or cream use simultaneously"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Bateman Horne Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger